KoRV and primary bone neoplasia in koalas: indirect evidence, not evidence about FeLV in cats
Veterinary pathology · 2026
In plain language
This study is not about cats or FeLV. It is about koala retrovirus in koala bone tumor samples. It found KoRV signals in those samples, but it does not show that the virus caused the tumors. It gives no direct evidence about FeLV diagnosis, treatment, or outcomes in cats.
Scientific detail
The 2026 Veterinary Pathology article investigated the association between koala retrovirus and primary bone neoplasia in koalas using real-time PCR and a novel immunohistochemistry assay. The available object describes bone tumor samples n = 14 and healthy bone samples n = 11. The species field in the structured study entry is UNKNOWN, although the title and stated relevance place the work in koalas.
According to the reviewed claims, relative KoRV-A proviral load was significantly lower in bone tumor samples than in healthy bone samples. Immunohistochemistry detected KoRV capsid protein expression in all examined koala bone tumor samples. The bone tumor group had a higher median KoRV capsid immunohistochemistry H-score than the control group.
Among the reported tumor subtypes, osteosarcomas had the highest mean percentage of KoRV-positive tumor-cell labeling. These findings describe associations and labeling patterns in koala tissue. They do not establish causation, mechanism, or preferential causation of osteosarcoma by KoRV.
The relevance to FeLV is indirect only. The study concerns KoRV in koalas, not feline leukemia virus in cats. It provides no direct evidence about FeLV pathogenesis, treatment, diagnosis, or clinical outcomes in cats. Only the abstract/source excerpt was provided, so full methodological details, control matching, replication status, and causal testing are not reported here.
What we know
The provided evidence supports that, in the described koala samples, relative KoRV-A proviral load was lower in bone tumors than in healthy bone; KoRV capsid protein was detected by immunohistochemistry in all examined bone tumors; the median capsid H-score was higher in the tumor group than in controls; and osteosarcomas had the highest mean percentage of KoRV-positive tumor-cell labeling among the reported subtypes. The claims are evidence level D and do not demonstrate causation.
What we don't know
This object does not show whether KoRV caused the bone tumors, what the mechanism would be, whether the findings replicate, or how controls were matched. It also tells us nothing directly about FeLV in cats: there is no evidence here on feline pathogenesis, diagnosis, treatment, prognosis, or clinical outcomes.
Evidence
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 98/100
In this koala study, relative KoRV-A proviral load was significantly lower in bone tumor samples than in healthy bone samples.
Excerpt verified in the source — verbatim, in the source's own language“The relative KoRV subtype A proviral load was significantly lower in bone tumor samples ( n = 14) when compared to healthy bone samples ( n = 11) ( P = .025), while other subtype-specific proviral loads did not differ significantly between tumor and healthy controls.”
This supports a reported association between KoRV-A proviral load and bone tumor status in koalas. It does not establish causation and does not provide direct evidence for FeLV in cats.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 99/100
The study detected KoRV capsid protein expression in all examined koala bone tumor samples by immunohistochemistry.
Excerpt verified in the source — verbatim, in the source's own language“Immunolabeling revealed KoRV capsid protein expression in all bone tumor samples (14/14, 100%), with an overall mean positive immunolabeling of 50.4% of tumor cells.”
This shows KoRV capsid protein was detected in all sampled koala bone tumors in this study. It does not show that KoRV caused the tumors and does not establish any feline claim.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 98/100
The koala bone tumor group had a higher median KoRV capsid immunohistochemistry H-score than the control group.
Excerpt verified in the source — verbatim, in the source's own language“The bone tumor group had a higher median H-score compared to the control group ( P < .001).”
This supports stronger KoRV capsid immunolabeling in koala bone tumor samples than controls as measured by H-score. It does not establish mechanism, causality, or relevance to FeLV-positive cats.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 97/100
Among the koala tumor subtypes reported, osteosarcomas had the highest mean percentage of KoRV-positive tumor-cell labeling.
Excerpt verified in the source — verbatim, in the source's own language“Among tumor subtypes, the highest mean percentage of tumor cell labeling was observed in osteosarcomas (73.0%), followed by chondrosarcomas (51.6%) and osteochondromas (38.0%).”
This describes differential immunolabeling across koala bone tumor subtypes. It does not establish that KoRV preferentially causes osteosarcoma or that similar patterns occur in cats.
InferenceConfidence 95/100
The source does not provide direct evidence about FeLV in cats.
The document studies koala retrovirus and koala bone tumors, so any application to FeLV would be indirect and hypothesis-generating only.
Provenance
Source: Investigating the association between koala retrovirus and primary bone neoplasia in koalas (<i>Phascolarctos cinereus)</i> using real-time PCR and a novel immunohistochemistry assay.
AVA